|
|
|
Insider
Information: |
Rastetter William H |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
225,281 |
|
Indirect Shares
|
1,517,593 |
|
|
Direct
Value |
$19,810,310 |
|
|
Indirect Value
|
$97,473,871 |
|
|
Total
Shares |
1,742,874 |
|
|
Total
Value |
$117,284,181 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
Executive Chairman, Di... |
2005-02-23 |
50,676 |
2005-02-23 |
373,929 |
Premium* |
|
Illumina Inc |
ILMN |
Director |
2015-12-31 |
8,494 |
2015-12-31 |
86,680 |
Premium* |
|
Receptos, Inc. |
RCPT |
Director |
2015-08-27 |
0 |
2015-08-25 |
0 |
Premium* |
|
Fate Therapeutics Inc |
FATE |
Director |
2022-06-09 |
11,331 |
2022-06-09 |
606,093 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
103,039 |
2014-04-15 |
60,307 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2015-07-20 |
0 |
2020-02-03 |
390,584 |
Premium* |
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-01-02 |
51,741 |
2017-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ILMN |
Illumina Inc |
Director |
|
2015-01-20 |
4 |
AS |
$184.85 |
$3,023,894 |
D/D |
(16,000) |
5,953 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-03-31 |
4 |
A |
$193.28 |
$29,958 |
D/D |
155 |
6,108 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,910 |
8,018 |
0 |
- |
|
RCPT |
Receptos, Inc. |
Director |
|
2015-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,400 |
7,400 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-06-30 |
4 |
A |
$201.07 |
$29,959 |
D/D |
149 |
8,167 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2015-07-20 |
4 |
B |
$10.13 |
$392,779 |
I/I |
38,765 |
38,765 |
2.1 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2015-07-21 |
4 |
B |
$10.19 |
$624,199 |
I/I |
61,235 |
100,000 |
2.1 |
- |
|
RCPT |
Receptos, Inc. |
Director |
|
2015-08-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(332,234) |
0 |
0 |
- |
|
RCPT |
Receptos, Inc. |
Director |
|
2015-08-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,400) |
0 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-09-30 |
4 |
A |
$205.90 |
$29,856 |
D/D |
145 |
8,312 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-12-31 |
4 |
A |
$164.14 |
$29,873 |
D/D |
182 |
8,494 |
0 |
- |
|
DARE |
Dare Bioscience Inc |
Director |
|
2016-10-03 |
4 |
A |
$1.02 |
$18,750 |
D/D |
18,382 |
78,689 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2016-11-23 |
4 |
B |
$2.66 |
$999,998 |
I/I |
375,939 |
459,272 |
2.1 |
- |
|
DARE |
Dare Bioscience Inc |
Director |
|
2017-01-03 |
4 |
A |
$0.77 |
$18,750 |
D/D |
24,350 |
103,039 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2017-02-01 |
4 |
OE |
$2.17 |
$54,250 |
D/D |
25,000 |
25,000 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2017-02-01 |
4 |
AS |
$42.28 |
$454,510 |
D/D |
(10,750) |
14,250 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2017-07-25 |
4 |
B |
$0.91 |
$250,000 |
I/I |
274,725 |
624,625 |
2.1 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2017-12-04 |
4 |
A |
$0.89 |
$61,999 |
I/I |
69,662 |
694,387 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2018-01-24 |
4 |
AS |
$90.00 |
$855,000 |
D/D |
(9,500) |
24,750 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2018-01-24 |
4 |
OE |
$7.05 |
$141,000 |
D/D |
20,000 |
34,250 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2018-11-12 |
4 |
A |
$0.00 |
$0 |
I/I |
23,258 |
79,672 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2019-05-07 |
4 |
B |
$1.08 |
$100,320 |
I/I |
92,889 |
154,223 |
2.1 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2019-05-07 |
4/A |
A |
$1.08 |
$100,320 |
I/I |
92,889 |
154,223 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2020-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
225,940 |
390,584 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2020-03-30 |
4 |
OE |
$1.37 |
$38,992 |
D/D |
28,461 |
28,461 |
0 |
- |
|
105 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|